Related posts
Stocks modestly extend sellingThis summary was created by AI, based on 2 opinions in the last 12 months.
Experts are closely monitoring Florida's upcoming vote to legalize cannabis as it could have a significant impact on the industry. Canopy Growth is seen as a leading player in this space, and its partnership with Constellation Brands adds to its appeal. Despite recent fluctuations in share prices, the overall trend has been positive, with significant gains since the potential for US legalization was first mentioned. The recent statements by President Biden and Florida's decision to put the legalization question on the ballot have further fueled interest in Canopy Growth.
Has followed this for along time. Constellation Brands owns a large stake in this. Shares are up 135% in the past month, though gave back in recent session. It's still more than doubled since he heard of possible legalization of weed in the U.S. Pres. Biden mentioned full legalization on March 7 and just today Florida said it will place the legalization question on the ballot.
Canopy is the way to play cannabis as we enter a Biden adminIstration. Also, Canopy has the interest of Constellation Brands.
Investors are betting on the Blue Wave, a Democratic sweep. Though Biden hasn't said he'll legalize cannabis, the Dems will make it easier for the cannabis industry to operate. Of note, recreational grass is already legal in 11 states and DC; recreational weed is on the ballot in three states on Nov. 3; and two-thirds of American believe it should be legal, even more when it comes to medicinal grass. No, we won't see a boom in Canadian weed, but instead American companies because American politicians need to serve American businesses first. Canada teaches us that when you legalize weed, EVERYBODY grows it, supply surges, driving the price down and companies don't make money. The one exception is Canopy. One reason is its relationship with Constellation Brands and carries the potential of weed-infused drinks and a leg up against competitors. Canopy itself has been a dog, but is lately showing some life.
Canopy Growth is a American stock, trading under the symbol CGC-N on the New York Stock Exchange (CGC). It is usually referred to as NYSE:CGC or CGC-N
In the last year, 2 stock analysts published opinions about CGC-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Canopy Growth.
Canopy Growth was recommended as a Top Pick by on . Read the latest stock experts ratings for Canopy Growth.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Canopy Growth In the last year. It is a trending stock that is worth watching.
On 2024-11-15, Canopy Growth (CGC-N) stock closed at a price of $3.73.
Florida's upcoming vote to legalize cannabis could impact the industry. Canopy is the go-to name,